[1]
M. E. D. Fialho, T. D. Alonso, G. L. Alves, R. B. Ribeiro, and C. M. Marinho, “CLINICAL MANAGEMENT OF CARDIOTOXICITY INDUCED BY IMMUNE CHECKPOINT INHIBITORS IN CANCER PATIENTS”, REASE, vol. 10, no. 8, pp. 212–223, Aug. 2024, doi: 10.51891/rease.v10i8.15121.